| Item |
Information |
|
Drug Groups
|
approved |
|
Description
|
Pivmecillinam is a mecillinam prodrug, a pivaloyloxymethyl ester of amdinocillin that is well absorbed orally, but broken down to amdinocillin in the intestinal mucosa. It is active against gram-negative organisms and used as for amdinocillin. [PubChem] |
| Indication |
Used to treat infections due to mecillinam-sensitive organisms such as urinary tract infections, salmonellosis and typhoid fever. |
| Pharmacology |
Pivmecillinam is a pivaloyloxymethyl ester of amdinocillin that is well absorbed orally, but broken down to amdinocillin in the intestinal mucosa. It is active against gram-negative organisms and used as for amdinocillin. |
| Affected Organisms |
| • |
Enteric bacteria and other eubacteria |
|
| Absorption |
Well absorbed following oral administration. |
| References |
| • |
Sjovall J, Huitfeldt B, Magni L, Nord CE: Effect of beta-lactam prodrugs on human intestinal microflora. Scand J Infect Dis Suppl. 1986;49:73-84.
[Pubmed]
|
| • |
Graninger W: Pivmecillinam--therapy of choice for lower urinary tract infection. Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:73-8.
[Pubmed]
|
| • |
Pivmecillinam (selexid). Drug Ther Bull. 1978 Dec 22;16(26):103-4.
[Pubmed]
|
|